See also this year's filing and all EDGAR filings for this company.
PDF Report 0001743881_2023_BridgeBio_Pharma_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 2.1588702231211254, 'aggregate_val': 1867960000, 'exp_sum': 591338000, 'exp_to_value': {'LiabilitiesCurrent': 121428000, 'LiabilitiesNoncurrent': 469910000, 'remainder_Liabilities': 0}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001743881, BridgeBio Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 548,853,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 28,712,000 |
| 2 | PropertyPlantAndEquipmentNet | 14,569,000 |
| 3 | remainder_Assets | 30,902,000 |
| 4 | LiabilitiesCurrent | 121,428,000 |
| 5 | LiabilitiesNoncurrent | 469,910,000 |
| 6 | remainder_Liabilities | 1,276,622,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 143,189,000 |
| 9 | ResearchAndDevelopmentExpense | 399,462,000 |
| 10 | remainder_Expenses | 47,199,000 |
| 11 | remainder_Revenues | 77,648,000 |
| 12 | remainder_NetIncome | 27,550,000 |
| 13 | remainder_ComprehensiveNetIncome | 3,273,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 623,036,000 |
| 1 | Liabilities | 1,867,960,000 |
| 2 | Expenses | 589,850,000 |
| 3 | Revenues | 77,648,000 |
| 4 | StockholdersEquity | -1,244,924,000 |
| 5 | NetIncome | -484,652,000 |
| 6 | ComprehensiveNetIncome | -483,015,500 |
| 7 | BaseVar | 1,594,658,500 |
| 8 | EconomicCapitalRatio | -2.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
